These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 19694729

  • 1. Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha.
    Huang XS, Zhao SP, Bai L, Hu M, Zhao W, Zhang Q.
    Br J Pharmacol; 2009 Oct; 158(3):706-12. PubMed ID: 19694729
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats.
    Roglans N, Sanguino E, Peris C, Alegret M, Vázquez M, Adzet T, Díaz C, Hernández G, Laguna JC, Sánchez RM.
    J Pharmacol Exp Ther; 2002 Jul; 302(1):232-9. PubMed ID: 12065722
    [Abstract] [Full Text] [Related]

  • 4. The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial.
    Black RN, Ennis CN, Young IS, Hunter SJ, Atkinson AB, Bell PM.
    J Diabetes Complications; 2014 Jul; 28(3):323-7. PubMed ID: 24560135
    [Abstract] [Full Text] [Related]

  • 5. Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4.
    Sanguino E, Roglans N, Alegret M, Sánchez RM, Vázquez-Carrera M, Laguna JC.
    Br J Pharmacol; 2005 Aug; 145(7):853-61. PubMed ID: 15912134
    [Abstract] [Full Text] [Related]

  • 6. Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression.
    Pierno S, Camerino GM, Cippone V, Rolland JF, Desaphy JF, De Luca A, Liantonio A, Bianco G, Kunic JD, George AL, Conte Camerino D.
    Br J Pharmacol; 2009 Apr; 156(8):1206-15. PubMed ID: 19220292
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Atorvastatin might inhibit insulin resistance induced by insulin through the triglyceride-lowering role of Apolipoprotein AV.
    Zhao W, Zhao SP.
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(20):3895-903. PubMed ID: 26531276
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [A dyslipidemia animal model induced by poloxamer 407 in golden hamsters and pilot study on the mechanism].
    Liu Q, Liu SN, Li LY, Chen ZY, Lei L, Zhang N, Shen ZF.
    Yao Xue Xue Bao; 2011 Apr; 46(4):406-11. PubMed ID: 21751494
    [Abstract] [Full Text] [Related]

  • 14. Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome.
    Chan DC, Watts GF, Ooi EM, Ji J, Johnson AG, Barrett PH.
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1831-7. PubMed ID: 18566295
    [Abstract] [Full Text] [Related]

  • 15. Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats.
    Dorfmeister B, Brandlhofer S, Schaap FG, Hermann M, Fürnsinn C, Hagerty BP, Stangl H, Patsch W, Strobl W.
    Diabetologia; 2006 Jun; 49(6):1324-32. PubMed ID: 16570166
    [Abstract] [Full Text] [Related]

  • 16. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
    Kockx M, Gervois PP, Poulain P, Derudas B, Peters JM, Gonzalez FJ, Princen HM, Kooistra T, Staels B.
    Blood; 1999 May 01; 93(9):2991-8. PubMed ID: 10216095
    [Abstract] [Full Text] [Related]

  • 17. Hypolipidemic drugs affect monocyte IL-1beta gene expression and release in patients with IIa and IIb dyslipidemia.
    Okopien B, Huzarska M, Kulach A, Stachura-Kulach A, Madej A, Belowski D, Zielinski M, Herman ZS.
    J Cardiovasc Pharmacol; 2005 Feb 01; 45(2):160-4. PubMed ID: 15654265
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Atorvastatin increases hepatic fatty acid beta-oxidation in sucrose-fed rats: comparison with an MTP inhibitor.
    Funatsu T, Kakuta H, Takasu T, Miyata K.
    Eur J Pharmacol; 2002 Nov 29; 455(2-3):161-7. PubMed ID: 12445582
    [Abstract] [Full Text] [Related]

  • 20. The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element.
    Prieur X, Coste H, Rodriguez JC.
    J Biol Chem; 2003 Jul 11; 278(28):25468-80. PubMed ID: 12709436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.